Homeopathy 2014; 103(01): 22-43
DOI: 10.1016/j.homp.2013.08.002
Review
Copyright © The Faculty of Homeopathy 2013

High-dilution effects revisited. 2. Pharmacodynamic mechanisms

Paolo Bellavite
1   Department of Pathology and Diagnostics, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy
,
Marta Marzotto
1   Department of Pathology and Diagnostics, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy
,
Debora Olioso
1   Department of Pathology and Diagnostics, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy
,
Elisabetta Moratti
1   Department of Pathology and Diagnostics, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy
,
Anita Conforti
2   Department of Public Health and Community Medicine, University of Verona, Piazza L.A. Scuro 10, 37134 Verona, Italy
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received31 July 2013

accepted12 August 2013

Publication Date:
10 January 2018 (online)

The pharmacodynamics aspects of homeopathic remedies are appraised by laboratory studies on the biological effects at various levels (cellular, molecular and systemic). The major question is how these medicines may work in the body. The possible answers concern the identification of biological targets, the means of drug–receptor interactions, the mechanisms of signal transmission and amplification, and the models of inversion of effects according to the traditional ‘simile’ rule. These problems are handled by two experimental and theoretical lines, according to the doses or dilutions considered (low-medium versus high dilutions). Homeopathic formulations in low-medium dilutions, containing molecules in the range of ultra-low doses, exploit the extreme sensitivity of biological systems to exogenous and endogenous signals. Their effects are interpreted in the framework of hormesis theories and paradoxical pharmacology. The hypotheses regarding the action mechanisms of highly diluted/dynamized solutions (beyond Avogadro–Loschmidt limit) variously invoke sensitivity to bioelectromagnetic information, participation of water chains in signalling, and regulation of bifurcation points of systemic networks. High-dilution pharmacology is emerging as a pioneering subject in the domain of nanomedicine and is providing greater plausibility to the puzzling claims of homeopathy.

 
  • References

  • 1 Bellavite P., Marzotto M., Olioso D., Moratti E., Conforti A. High-dilution effects revisited. 1. Physicochemical aspects. Homeopathy 2014; 103: 4-21.
  • 2 Witt C.M., Bluth M., Albrecht H., Weisshuhn T.E., Baumgartner S., Willich S.N. The in vitro evidence for an effect of high homeopathic potencies – a systematic review of the literature. Complement Ther Med 2007; 15: 128-138.
  • 3 Bonamin L.V., Endler P.C. Animal models for studying homeopathy and high dilutions: conceptual critical review. Homeopathy 2010; 99: 37-50.
  • 4 Bellavite P., Magnani P., Marzotto M., Conforti A. Assays of homeopathic remedies in rodent behavioural and psychopathological models. Homeopathy 2009; 98: 208-227.
  • 5 Endler P., Thieves K., Reich C. et al. Repetitions of fundamental research models for homeopathically prepared dilutions beyond 10(-23): a bibliometric study. Homeopathy 2010; 99: 25-36.
  • 6 Poitevin B., Davenas E., Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica . Br J Clin Pharmacol 1988; 25: 439-444.
  • 7 Cherruault Y., Guillez A., Sainte-Laudy J., Belon P. Étude mathematique et statistique des effets de dilutions successives de chlorhydrate d'histamine sur la réactivité des basophiles humains. Bio-Sciences 1989; 7: 63-72.
  • 8 Brown V., Ennis M. Flow-cytometric analysis of basophil activation: inhibition by histamine at conventional and homeopathic concentrations. Inflamm Res 2001; 50 (02) S47-S48.
  • 9 Lorenz I., Schneider E.M., Stolz P., Brack A., Strube J. Influence of the diluent on the effect of highly diluted histamine on basophil activation. Homeopathy 2003; 92: 11-18.
  • 10 Lorenz I., Schneider E.M., Stolz P., Brack A., Strube J. Sensitive flow cytometric method to test basophil activation influenced by homeopathic histamine dilutions. Forsch Komplementarmed Klass Naturheilkd 2003; 10: 316-324.
  • 11 Sainte-Laudy J., Boudjedaini N., Belon P. Differential effect of storage on molecular and ultra-molecular dilutions of histamine. Inflamm Res 2009; 58 (Suppl. 01) 30-31.
  • 12 Sainte-Laudy J., Boujenaini N., Belon P. Confirmation of biological effects of high dilutions. Effects of submolecular concentrations of histamine and 1-, 3- and 4-methylhistamines on human basophil activation. Inflamm Res 2008; 57 (Suppl. 01) S27-S28.
  • 13 Chirumbolo S., Brizzi M., Ortolani R., Vella A., Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res 2009; 58: 755-764.
  • 14 Sainte-Laudy J., Belon P. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions. Homeopathy 2009; 98: 186-197.
  • 15 Guggisberg A.G., Baumgartner S.M., Tschopp C.M., Heusser P. Replication study concerning the effects of homeopathic dilutions of histamine on human basophil degranulation in vitro. Complement Ther Med 2005; 13: 91-100.
  • 16 Walchli C., Baumgartner S. Flow cytometric analysis of the inhibition of human basophil activation by histamine high dilutions – a replication study. Int J High Dilution Res 2012; 11 (40) 172-173.
  • 17 Sainte-Laudy J., Belon P. Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil activation: effect of cimetidine. Inflamm Res 1997; 46: S27-S28.
  • 18 Khuda-Bukhsh A.R., Bhattacharyya S.S., Paul S., Dutta S., Boujedaini N., Belon P. Modulation of signal proteins: a plausible mechanism to explain how a potentized drug Secale Cor 30C diluted beyond Avogadro's limit combats skin papilloma in mice. Evid Based Complement Alternat Med 2011. 2011 286320.
  • 19 Endler P.C., Pongratz W., Kastberger G., Wiegant F.A., Schulte J. The effect of highly diluted agitated thyroxine on the climbing activity of frogs. Vet Hum Toxicol 1994; 36: 56-59.
  • 20 Endler P.C., Ludtke R., Heckmann C. et al. Pretreatment with thyroxine (10−8 parts by weight) enhances a ‘curative’ effect of homeopathically prepared thyroxine (10−13) on lowland frogs. Forsch Komplementarmed Klass Naturheilkd 2003; 10: 137-142.
  • 21 Weber S., Endler P.C., Welles S.U. et al. The effect of homeopathically prepared thyroxine on highland frogs: influence of electromagnetic fields. Homeopathy 2008; 97: 3-9.
  • 22 Guedes J.R., Ferreira C.M., Guimaraes H.M., Saldiva P.H., Capelozzi V.L. Homeopathically prepared dilution of Rana catesbeiana thyroid glands modifies its rate of metamorphosis. Homeopathy 2004; 93: 132-137.
  • 23 Guedes J.R., Carrasco S., Ferreira C.M. et al. Ultra high dilution of triiodothyronine modifies cellular apoptosis in Rana catesbeiana tadpole tail in vitro. Homeopathy 2011; 100: 220-227.
  • 24 Harrer B. Replication of an experiment on extremely diluted thyroxine and highland amphibians. Homeopathy 2013; 102: 25-30.
  • 25 Bellavite P., Conforti A., Pontarollo F., Ortolani R. Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med 2006; 3: 13-24.
  • 26 Bellavite P., Conforti A., Ortolani R. Immunology and homeopathy. 3. Experimental studies on animal models. Evid Based Complement Alternat Med 2006; 3: 171-186.
  • 27 Bellavite P., Marzotto M., Chirumbolo S., Conforti A. Advances in homeopathy and immunology: a review of clinical research. Front Biosci (Schol Ed) 2011; 3: 1363-1389.
  • 28 Hostanska K., Rostock M., Melzer J., Baumgartner S., Saller R. A homeopathic remedy from arnica, marigold, St. John inverted question marks wort and comfrey accelerates in vitro wound scratch closure of NIH 3T3 fibroblasts. BMC Complement Altern Med 2012; 12: 100.
  • 29 Lussignoli S., Bertani S., Metelmann H., Bellavite P., Conforti A. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med 1999; 7: 225-230.
  • 30 Kawakami A.P., Sato C., Cardoso T.N., Bonamin L.V. Inflammatory process modulation by homeopathic Arnica montana 6CH: the role of individual variation. Evid Based Complement Alternat Med 2011. 2011 917541.
  • 31 de Oliveira S.M., de Oliveira C.C., Abud A.P. et al. Mercurius solubilis: actions on macrophages. Homeopathy 2011; 100: 228-236.
  • 32 de Araujo F.R., de Castro C.M., Severo M.S., Diniz M.F., Viana M.T., Evencio L.B. Effect of Mercurius solubilis on the bacteriological response in the alveolitis process in rats. Homeopathy 2009; 98: 160-164.
  • 33 Davenas E., Poitevin B., Benveniste J. Effect on mouse peritoneal macrophages of orally administered very high dilutions of silica. Eur J Pharmacol 1987; 135: 313-319.
  • 34 Oberbaum M., Weisman Z., Kalinkovich A., Bentwich Z. Healing chronic wounds performed on mouse ears using silica (SiO2) as a homeopathic remedy. Pharmacological study of homeopathic high dilutions. In: Bastide M. (ed). Signals Images. 1997. Dordrecht: Kluwer; 191-199.
  • 35 Boericke W. Materia Medica with repertory. Philadelphia: Boericke & Tafel, Inc.; 1927.
  • 36 Binsard A.M., Guillemain J., Platel A., Savini E.C., Tetau M. Étude psycho-pharmacologique de dilutions homéopathiques de Gelsemium et d'Ignatia. Ann Homeop Fr 1980; 22: 35-50.
  • 37 Guillemain J., Rousseau A., Dorfman P., Tetau M. Recherche en psychopharmacologie. Cah Biother 1989; 103: 53-66.
  • 38 Guermonprez M. Homéopathie, principles – clinique – techniques. Paris: CEDH; 2006.
  • 39 Schun Y., Cordell G.A. Cytotoxic steroids of Gelsemium sempervirens . J Nat Prod 1987; 50: 195-198.
  • 40 Dutt V., Thakur S., Dhar V.J., Sharma A. The genus Gelsemium: an update. Pharmacogn Rev 2010; 4: 185-194.
  • 41 Gahlot K., Abid M., Sharma A. Pharmacological evaluation of Gelsemium sempervirens roots for CNS depressant activity. Int J Pharm Tech Res 2012; 3: 693-697.
  • 42 Dutt V., Dhar V.J., Sharma A. Antianxiety activity of Gelsemium sempervirens . Pharm Biol 2010; 48: 1091-1096.
  • 43 Liu M., Shen J., Liu H. et al. Gelsenicine from Gelsemium elegans attenuates neuropathic and inflammatory pain in mice. Biol Pharm Bull 2011; 34: 1877-1880.
  • 44 Xu Y., Qiu H.Q., Liu H. et al. Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone. Pharmacol Biochem Behav 2012; 101: 504-514.
  • 45 Venard C., Boujedaini N., Belon P., Mensah-Nyagan A.G., Patte-Mensah C. Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 2008; 153: 154-161.
  • 46 Venard C., Boujedaini N., Mensah-Nyagan A.G., Patte-Mensah C. Comparative analysis of gelsemine and Gelsemium sempervirens aftivity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid Based Complement Alternat Med 2011. 2011 407617.
  • 47 Bhattacharyya S.S., Mandal S.K., Biswas R. et al. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens . Exp Biol Med (Maywood) 2008; 233: 1591-1601.
  • 48 Zhao Q.C., Hua W., Zhang L. et al. Antitumor activity of two gelsemine metabolites in rat liver microsomes. J Asian Nat Prod Res 2010; 12: 731-739.
  • 49 Rammal H., Soulimani R. Effects of high doses of Gelsemium sempervirens L. on GABA receptor and on the cellular and humoral immunity in mice. JMMS 2010; 1: 40-44.
  • 50 Das S., Das J., Samadder A., Bhattacharyya S.S., Das D., Khuda-Bukhsh A.R. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces 2013; 101: 325-336.
  • 51 Datta S., Mallick P., Bukhsh A.R. Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses. Complement Ther Med 1999; 7: 156-163.
  • 52 Das S., Saha S.K., De A., Das D., Khuda-Bukhsh A.R. Potential of the homeopathic remedy, Arnica Montana 30C, to reduce DNA damage in Escherichia coli exposed to ultraviolet irradiation through up-regulation of nucleotide excision repair genes. Zhong Xi Yi Jie He Xue Bao 2012; 10: 337-346.
  • 53 Das D., De A., Dutta S., Biswas R., Boujedaini N., Khuda-Bukhsh A.R. Potentized homeopathic drug Arsenicum album 30C positively modulates protein biomarkers and gene expressions in Saccharomyces cerevisae exposed to arsenate. Zhong Xi Yi Jie He Xue Bao 2011; 9: 752-760.
  • 54 Paul A., Das S., Das J., Samadder A., Khuda-Bukhsh A.R. Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo. Toxicol Lett 2013; 222: 10-22.
  • 55 Saha S.K., Khuda-Bukhsh A.R. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. Eur J Pharmacol 2013; 714: 239-248.
  • 56 de Oliveira C.C., de Oliveira S.M., Goes V.M., Probst C.M., Krieger M.A., Buchi D.F. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem 2008; 104: 1364-1377.
  • 57 Bigagli E., Luceri C., Bernardini S., Dei A., Dolara P. Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact 2010; 188: 214-219.
  • 58 Preethi K., Ellanghiyil S., Kuttan G., Kuttan R. Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: implications on mechanism of action. Integr Cancer Ther 2012; 11: 172-182.
  • 59 Bellavite P., Marzotto M., Olioso D. et al. Cellular and transcriptional responses of SH-SY5Y human neurocytes following in vitro exposure to Gelsemium sempervirens . Int J High Dilution Res 2012; 11: 144-146.
  • 60 Shepperd J. Chaos theory: implications for homeopathy. J Am Inst Homeopathy 1994; 87: 22-29.
  • 61 Bell F. The complex ‘whole’: exploring homoeopathic and spiritual considerations. Aust J Holist Nurs 2000; 7: 31-35.
  • 62 Milgrom L.R. Vitalism, complexity and the concept of spin. Homeopathy 2002; 91: 26-31.
  • 63 Bellavite P. Complexity science and homeopathy. A synthetic overview. Homeopathy 2003; 92: 203-212.
  • 64 Bell I.R., Lewis D.A., Lewis S.E., Brooks A.J., Schwartz G.E., Baldwin C.M. Strength of vital force in classical homeopathy: bio-psycho-social-spiritual correlates within a complex systems context. J Altern Complement Med 2004; 10: 123-131.
  • 65 Bell I.R., Howerter A., Jackson N., Aickin M., Bootzin R.R., Brooks A.J. Nonlinear dynamical systems effects of homeopathic remedies on multiscale entropy and correlation dimension of slow wave sleep EEG in young adults with histories of coffee-induced insomnia. Homeopathy 2012; 101: 182-192.
  • 66 Callard R., George A.J., Stark J. Cytokines, chaos, and complexity. Immunity 1999; 11: 507-513.
  • 67 Glattre E., Nygard J.F. Fractal meta-analysis and ‘causality’ embedded in complexity: advanced understanding of disease etiology. Nonlinear Dynamics Psychol Life Sci 2004; 8: 315-344.
  • 68 Martinez-Lavin M., Infante O., Lerma C. Hypothesis: the chaos and complexity theory may help our understanding of fibromyalgia and similar maladies. Semin Arthritis Rheum 2008; 37: 260-264.
  • 69 Higgins J.P. Nonlinear systems in medicine. Yale J Biol Med 2002; 75: 247-260.
  • 70 Del Prete G. The complexity of the CD4 T-cell responses: old and new T-cell subsets. Parassitologia 2008; 50: 9-16.
  • 71 Sukul N.C., Batuev A.S., Sabanov V., Kourzina N.P. Neuronal activity in the lateral hypothalamus of the cat the medial frontal cortex of the rat in response to homoeopathic drugs. Indian Biologist 1991; 23 (02) 17-21.
  • 72 Sukul N.C., Sukul A. High dilution effects: physical and biochemical basis. Dordrecht: Kluwer; 2003.
  • 73 Levin M., Stevenson C.G. Regulation of cell behavior and tissue patterning by bioelectrical signals: challenges and opportunities for biomedical engineering. Annu Rev Biomed Eng 2012; 14: 295-323.
  • 74 Bell I.R., Baldwin C.M., Fernandez M., Schwartz G.E. Neural sensitization model for multiple chemical sensitivity: overview of theory and empirical evidence. Toxicol Ind Health 1999; 15: 295-304.
  • 75 Popp F.A. Principles of complementary medicine in terms of a suggested scientific basis. Indian J Exp Biol 2008; 46: 378-383.
  • 76 Ruiz G., Torres J.L., Michel O., Navarro R. Homeopathic effect on heart rate variability. Br Homeopath J 1999; 88: 106-111.
  • 77 Ruiz-Vega G., Perez-Ordaz L., Cortes-Galvan L., Juarez G. A kinetic approach to caffeine – Coffea cruda interaction. Homeopathy 2003; 92: 19-29.
  • 78 Ruiz-Vega G., Perez-Ordaz L., Leon-Hueramo O., Cruz-Vazquez E., Sanchez-Diaz N. Comparative effect of Coffea cruda potencies on rats. Homeopathy 2002; 91: 80-84.
  • 79 Ruiz-Vega G., Perez-Ordaz L., Proa-Flores P., Aguilar-Diaz Y. An evaluation of Coffea cruda effect on rats. Br Homeopath J 2000; 89: 122-126.
  • 80 Ruiz-Vega G., Poitevin B., Perez-Ordaz L. Histamine at high dilution reduces spectral density in delta band in sleeping rats. Homeopathy 2005; 94: 86-91.
  • 81 Ruiz-Vega G., Estevez-Delgado G. Non-linearity modeling of ultra-dilutions: the histamine disturbances case. In: Bonamin L.V. (ed). Signals and Images. Contributions and Contradictions About High Dilution Research. 2008. Springer Science; 67-82.
  • 82 Bell I.R., Lewis D.A., Schwartz G.E. et al. Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. J Altern Complement Med 2004; 10: 285-299.
  • 83 Bell I.R., Howerter A., Jackson N., Brooks A.J., Schwartz G.E. Multiweek resting EEG cordance change patterns from repeated olfactory activation with two constitutionally salient homeopathic remedies in healthy young adults. J Altern Complement Med 2012; 18: 445-453.
  • 84 Bellavite P., Conforti A., Marzotto M. et al. Testing homeopathy in mouse emotional response models: pooled data analysis of two series of studies. Evid Based Complement Alternat Med 2012. 2012 954374.
  • 85 Bellavite P., Signorini A. Pathology, complex systems and resonance. In: Schulte J., Endler P.C. (eds). Fundamental Research in Ultra-high Dilution and Homoeopathy. 1998. Dordrecht, The Netherlands: Kluwer Acad. Publ.; 105-116.
  • 86 Bellavite P., Signorini A. The emerging science of homeopathy: complexity, biodynamics, and nanopharmacology. Berkeley (CA): North Atlantic; 2002.
  • 87 Bellavite P. La complessità in medicina. Fondamenti di un approccio sistemico e dinamico alla salute, alla malattia e alle terapie integrate. Milano: Tecniche Nuove; 2009.
  • 88 Vandenberg L.N., Colborn T., Hayes T.B. et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012; 33: 378-455.
  • 89 Thangapazham R.L., Rajeshkumar N.V., Sharma A. et al. Effect of homeopathic treatment on gene expression in Copenhagen rat tumor tissues. Integr Cancer Ther 2006; 5: 350-355.
  • 90 Bellavite P., Chirumbolo S., Marzotto M. Hormesis and its relationship with homeopathy. Hum Exp Toxicol (BELLE Newsl) 2010; 16: 11-18.
  • 91 Bellavite P., Ortolani R., Pontarollo F., Pitari G., Conforti A. Immunology and homeopathy. 5. The rationale of the ‘Simile’. Evid Based Complement Alternat Med 2007; 4: 149-163.
  • 92 Torres J.L. Enhanced susceptibility in homeopathic experiments. London: Royal London Homeopathic Hospital Ed.; 2003.
  • 93 Van Wijk R., Wiegant F.A. Postconditioning hormesis and the homeopathic similia principle: molecular aspects. Hum Exp Toxicol 2010; 29: 561-565.
  • 94 Wiegant F., Van W.R. The similia principle: results obtained in a cellular model system. Homeopathy 2010; 99: 3-14.
  • 95 Anick D.J., Ives J.A. The silica hypothesis for homeopathy: physical chemistry. Homeopathy 2007; 96: 189-195.
  • 96 Ives J.A., Moffett J.R., Arun P. et al. Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy 2010; 99: 15-24.
  • 97 Torres J.L., Ruiz G. Stochastic resonance and the homoeopathic effect. Br Homeopath J 1996; 85: 134-140.
  • 98 Schwartz G.E., Russek L.G., Bell I.R., Riley D. Plausibility of homeopathy and conventional chemical therapy: the systemic memory resonance hypothesis. Med Hypotheses 2000; 54: 634-637.
  • 99 Wiesenfeld K., Moss F. Stochastic resonance and the benefits of noise: from ice ages to crayfish and SQUIDs. Nature 1995; 373: 33-36.
  • 100 Yu H., Wang J., Liu C., Deng B., Wei X. Stochastic resonance on a modular neuronal network of small-world subnetworks with a subthreshold pacemaker. Chaos 2011. 21 047502.
  • 101 Teissie J. Biophysical effects of electric fields on membrane water interfaces: a mini review. Eur Biophys J 2007; 36: 967-972.
  • 102 Perc M., Marhl M. Noise enhances robustness of intracellular Ca2+ oscillations. Phys Lett A 2003; 316: 304-310.
  • 103 Freier E., Wolf S., Gerwert K. Proton transfer via a transient linear water-molecule chain in a membrane protein. Proc Natl Acad Sci U S A 2011; 108: 11435-11439.
  • 104 Nitzan A. Ultrafast relaxation in water. 1999: 472-475.
  • 105 Woutersen S., Bakker H.J. Resonant intermolecular transfer of vibrational energy in liquid water. 1999: 507-509.
  • 106 Grotthus C.J.T. Sur la decomposition de l'eau et des corps qu'elle tient en dissolution à l'aide de l'electricitè galvanique. Ann Chim 1806; 58: 54-73.
  • 107 Elia V., Napoli E., Niccoli M., Nonatelli L., Ramaglia A., Ventimiglia E. New physico-chemical properties of extremely diluted aqueous solutions. A calorimetric and conductivity study at 25 °C. J Thermal Anal Calorim 2004: 331-342.
  • 108 Holt J.K. Methods for probing water at the nanoscale. Microfluid Nanofluid 2008; 5: 425-442.
  • 109 Witt C., Ludtke R., Weisshuhn T.E., Willich S.N. High homeopathic potencies are different from potentized solvent when investigated with the REDEM technology. Forsch Komplementarmed Klass Naturheilkd 2005; 12: 6-13.
  • 110 Cifra M., Fields J.Z., Farhadi A. Electromagnetic cellular interactions. Prog Biophys Mol Biol 2011; 105: 223-246.
  • 111 Kolomytkin O.V., Dunn S., Hart F.X., Frilot C., Kolomytkin D., Marino A.A. Glycoproteins bound to ion channels mediate detection of electric fields: a proposed mechanism and supporting evidence. Bioelectromagnetics 2007; 28: 379-385.
  • 112 Weaver J.C., Astumian R.D. The response of living cells to very weak electric fields: the thermal noise limit. Science 1990; 247: 459-462.
  • 113 Ho M.W., Popp F.A., Warnke U. Bioelectrodynamics and biocommunication. Singapore: World Scientific; 1994.
  • 114 Popp F.A. Properties of biophotons and their theoretical implications. Indian J Exp Biol 2003; 41: 391-402.
  • 115 Schutgens F.W., Neogi P., van Wijk E.P., Van W.R., Wikman G., Wiegant F.A. The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment. Phytother Res 2009; 23: 1103-1108.
  • 116 Meyl K. DNA and cell resonance: magnetic waves enable cell communication. DNA Cell Biol 2012; 31: 422-426.
  • 117 Shang C. Emerging paradigms in mind-body medicine. J Altern Complement Med 2001; 7: 83-91.
  • 118 Bajpai R., Brizhik L., Del Giudice E., Finelli F., Popp F.A., Schlebusch K.P. Light as a trigger and a probe of the internal dynamics of living organisms. J Acupunct Meridian Stud 2010; 3: 291-297.
  • 119 Vickland V., Rogers C., Craig A., Tran Y. Electrodermal activity as a possible physiological marker for acupuncture. Complement Ther Clin Pract 2008; 14: 83-89.
  • 120 Pontarollo F., Rapacioli G., Bellavite P. Increase of electrodermal activity of heart meridian during physical exercise: the significance of electrical values in acupuncture and diagnostic importance. Complement Ther Clin Pract 2010; 16: 149-153.
  • 121 Smith C.W. Quanta and coherence effects in water and living systems. J Altern Complement Med 2004; 10: 69-78.
  • 122 Benveniste J., Guillonnet D. QED and digital biology. Riv Biol 2004; 97: 169-172.
  • 123 Thomas Y., Schiff M., Belkadi L., Jurgens P., Kahhak L., Benveniste J. Activation of human neutrophils by electronically transmitted phorbol-myristate acetate. Med Hypotheses 2000; 54: 33-39.
  • 124 Rossi C., Foletti A., Magnani A., Lamponi S. New perspectives in cell communication: bioelectromagnetic interactions. Semin Cancer Biol 2011; 21: 207-214.
  • 125 Jerman I., Ruziè R., Krasovec R., Mogilnicki L. Electrical transfer of molecule information into water, its storage, and bioeffects on plants and bacteria. Electromagn Biol Med 2005; 24: 341-353.
  • 126 Liboff A.R. Electric-field ion cyclotron resonance. Bioelectromagnetics 1997; 18: 85-87.
  • 127 Pazur A. Characterisation of weak magnetic field effects in an aqueous glutamic acid solution by nonlinear dielectric spectroscopy and voltammetry. Biomagn Res Technol 2004; 2: 8.
  • 128 Liboff A.R. Electric polarization and the viability of living systems: ion cyclotron resonance-like interactions. Electromagn Biol Med 2009; 28: 124-134.
  • 129 Foletti A., Lisi A., Ledda M., de Carlo F., Grimaldi S. Cellular ELF signals as a possible tool in informative medicine. Electromagn Biol Med 2009; 28: 71-79.
  • 130 Foletti A., Grimaldi S., Lisi A., Ledda M., Liboff A.R. Bioelectromagnetic medicine: the role of resonance signaling. Electromagn Biol Med 2013 Jan 16 http://dx.doi.org/10.3109/15368378.2012.743908 [Epub ahead of print].
  • 131 Montagnier L., Aissa J., Del Giudice E., Lavallee C., Tedeschi A. DNA waves and water. J Phys Conf Ser 2011. 306 012007.
  • 132 Montagnier L., Aissa J., Ferris S., Montagnier J.L., Lavallee C. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci: Comput Life Sci 2009; 1: 81-90.
  • 133 Montagnier L., Aissa J., Lavallee C., Mbamy M., Varon J., Chenal H. Electromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapy. Interdiscip Sci: Comput Life Sci 2009; 1: 245-253.
  • 134 Foletti A., Ledda M., D'Emilia E., Grimaldi S., Lisi A. Differentiation of human LAN-5 neuroblastoma cells induced by extremely low frequency electronically transmitted retinoic acid. J Altern Complement Med 2011; 17: 701-704.
  • 135 Foletti A., Ledda M., D'Emilia E., Grimaldi S., Lisi A. Experimental finding on the electromagnetic information transfer of specific molecular signals mediated through the aqueous system on two human cellular models. J Altern Complement Med 2012; 18: 258-261.
  • 136 Jonas W.B., Ives J.A., Rollwagen F. et al. Can specific biological signals be digitized?. FASEB J 2006; 20: 23-28.
  • 137 Fuxreiter M., Mezei M., Simon I., Osmany R. Interfacial water as a ‘hydration fingerprint’ in the noncognate complex of BamHI. Biophys J 2005; 89: 903-911.
  • 138 Moukhametzianov R., Klare J.P., Efremov R. et al. Development of the signal in sensory rhodopsin and its transfer to the cognate transducer. Nature 2006; 440: 115-119.
  • 139 Czerlinski G., Ypma T. The targets of information-carrying nanodomains. J Nanosci Nanotechnol 2012; 12: 2239-2247.
  • 140 Bell I.R., Koithan M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement Altern Med 2012; 12: 191.
  • 141 Szolnoki Z. A dynamically changing intracellular water network serves as a universal regulator of the cell: the water-governed cycle. Biochem Biophys Res Commun 2007; 357: 331-334.
  • 142 Khesbak H., Savchuk O., Tsushima S., Fahmy K. The role of water H-bond imbalances in B-DNA substate transitions and peptide recognition revealed by time-resolved FTIR spectroscopy. J Am Chem Soc 2011; 133: 5834-5842.
  • 143 Wei D., Wilson W.D., Neidle S. Small-molecule binding to the DNA minor groove is mediated by a conserved water cluster. J Am Chem Soc 2013; 135: 1369-1377.
  • 144 Marchettini N., Del G.E., Voeikov V., Tiezzi E. Water: a medium where dissipative structures are produced by a coherent dynamics. J Theor Biol 2010; 265: 511-516.
  • 145 Shahabi S., Kasariyans A., Noorbakhsh F. Like cures like: a neuroimmunological model based on electromagnetic resonance. Electromagn Biol Med 2013 Jan 23 http//dx.doi.org/10.3109/15368378.2012.743911. [Epub ahead of print].
  • 146 Bellavite P., Lussignoli S., Semizzi M., Ortolani R., Signorini A. The similia principle. From cellular models to regulation of homeostasis. Br Homeopath J 1997; 86: 73-85.
  • 147 Bellavite P., Andrioli G., Lussignoli S., Signorini A., Ortolani R., Conforti A. Scientific reappraisal of the “Principle of Similarity”. Med Hypotheses 1997; 49: 203-212.
  • 148 Andrioli G., Lussignoli S., Gaino S., Benoni G., Bellavite P. Study on paradoxical effects of NSAIDs on platelet activation. Inflammation 1997; 21: 519-530.
  • 149 Bond R.A. Is paradoxical pharmacology a strategy worth pursuing?. Trends Pharmacol Sci 2001; 22: 273-276.
  • 150 Yun A.J. The intellectual lineage of paradoxical pharmacology strategy. Med Hypotheses 2005; 65: 815.
  • 151 Teixeira M.Z. ‘Paradoxical strategy for treating chronic diseases’: a therapeutic model used in homeopathy for more than two centuries. Homeopathy 2005; 94: 265-266.
  • 152 Wiegant F.A., Souren J.E.M., Van Wijk R. Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in hsp-inducing effects. Hum Exp Toxicol 1999; 18: 460-470.
  • 153 Bernardini S., Dei A. Hormesis may provide a central concept for homeopathy development. Toxicol Appl Pharmacol 2006; 211: 84.
  • 154 Calabrese E.J. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem 2008; 27: 1451-1474.
  • 155 Jonas W.B., Ives J.A. Should we explore the clinical utility of hormesis?. Hum Exp Toxicol 2008; 27: 123-127.
  • 156 Calabrese E.J., Jonas W.B. Homeopathy: clarifying its relationship to hormesis. Hum Exp Toxicol 2010; 29: 531-536.
  • 157 Van Wijk R., Wiegant F.A. Postconditioning hormesis and the similia principle. Front Biosci (Elite Ed) 2011; 3: 1128-1138.
  • 158 Schulz H. Uber die Theorie der Arzneimittelwirkung. Virchow's Archiv 1877; 108: 423-434.
  • 159 Martius F. Das Arndt-Schulz Grundgesetz. Muench Med Wochenschr 1923; 70: 1005-1006.
  • 160 Boyd L.J. A study of the simile in medicine. Philadelphia: Boericke and Tafel; 1936.
  • 161 Calabrese E.J., Baldwin L.A. The marginalization of hormesis. Hum Exp Toxicol 2000; 19: 32-40.
  • 162 Calabrese E.J., Bachmann K.A., Bailer A.J. et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 2007; 222: 122-128.
  • 163 Stebbing A.R.D. Hormesis: the stimulation of growth by low levels of inhibitors. Sci Total Environ 1982; 22: 213-234.
  • 164 Wagner H., Kreher B., Jurcic K. In vitro stimulation of human granulocytes and lymphocytes by pico-and femtogram quantities of cytostatic agents. Arzneimittelforschung 1988; 38: 273-275.
  • 165 Von Zglinicki T., Edwall C., Ostlund E. et al. Very low cadmium concentrations stimulate DNA synthesis cell growth. J Cell Sci 1992; 103: 1073-1081.
  • 166 Van Wijk R., Wiegant F.A.C., Souren J.E.M., Ovelgonne J.H., van Aken J.M., Bol A.W.J.M. A molecular basis for understanding the benefits from subharmful doses of toxicants. Biomed Ther 1997; 15: 4-13.
  • 167 Wiegant F.A., Prins H.A., Van W.R. Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response 2011; 9: 209-224.
  • 168 Crain S.M., Shen K.F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci U S A 1995; 92: 10540-10544.
  • 169 Shen K.F., Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 1997; 757: 176-190.
  • 170 da Silva J.L., Morishita T., Escalante B. et al. Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress. J Lab Clin Med 1996; 128: 290-296.
  • 171 Andrioli G., Lussignoli S., Ortolani R., Minuz P., Vella F., Bellavite P. Dual effects of diclofenac on human platelet adhesion in vitro. Blood Coagul Fibrinolysis 1996; 7: 153-156.
  • 172 Bellavite P., Carletto A., Biasi D. et al. Studies of skin-window exudate human neutrophils: complex patterns of adherence to serum-coated surfaces in dependence on FMLP doses. Inflammation 1994; 18: 575-587.
  • 173 Chirumbolo S., Conforti A., Lussignoli S., Metelmann H., Bellavite P. Effects of Podophyllum peltatum compounds in various preparations dilutions on human neutrophil functions in vitro. Br Homeopath J 1997; 86: 16-26.
  • 174 Betti L., Brizzi M., Nani D., Peruzzi M. Effect of high dilutions of Arsenicum album on wheat seedlings from seed poisoned with the same substance. Br Homeopath J 1997; 86: 86-89.
  • 175 Betti L., Borghini F., Nani D. Plant models for fundamental research in homeopathy. Homeopathy 2003; 92: 129-130.
  • 176 Pongratz W., Nograsek A., Endler P.C. Highly diluted agitated silver nitrate and wheat seedling development. Effect kinetics of a process of successive agitation phases. In: Schulte J., Endler P.C. (eds). Fundamental Research in Ultra High Dilution and Homeopathy. 2000. Dordrecht: Kluwer; 143-154.
  • 177 Delbancut A., Dorfman P., Cambar J. Protective effect of very low concentrations of heavy metals cadmium and cisplatin against cytotoxic doses of these metals on renal tubular cell cultures. Br Homeopath J 1993; 82: 123-124.
  • 178 Walchli C., Baumgartner S., Bastide M. Effect of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study. J Altern Complement Med 2006; 12: 421-427.
  • 179 Jonas W., Lin Y., Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport 2001; 12: 335-339.
  • 180 Marotta D., Marini A., Banaudha K. et al. Non-linear effects of cycloheximide in glutamate-treated cultured rat cerebellar neurons. Neurotoxicology 2002; 23: 307-312.
  • 181 Chirumbolo S., Marzotto M., Conforti A., Vella A., Ortolani R., Bellavite P. Bimodal action of the flavonoid quercetin on basophil function: an investigation of the putative biochemical targets. Clin Mol Allergy 2010; 8: 13.
  • 182 Endler P.C., Pongratz W., Kastberger G., Wiegant F.A.C., Haidvogl M. Climbing activity in frogs the effect of highly diluted succussed thyroxine. Br Homeopath J 1991; 80: 194-200.
  • 183 Endler P.C., Pongratz W., Van Wijk R. et al. A zoological example on ultra high dilution research. Energetic coupling between the dilution the organism in a model of amphibia. In: Endler P.C., Schulte J. (eds). Ultra High Dilution. 1994. Dordrecht: Kluwer Acad. Publ.; 39-68.
  • 184 Doutremepuich C., Aguejouf O., Belon P. Effects of ultra-low-dose aspirin on embolization in a model of laser-induced thrombus formation. Semin Thromb Hemost 1996; 22 (Suppl. 01) 67-70.
  • 185 Eizayaga F.X., Aguejouf O., Desplat V., Doutremepuich C. Beneficial effect of ultra-low-dose aspirin in platelet activity alterations and haemorrhage observed in experimental portal hypertension. Thrombosis 2012. 2012 430460.
  • 186 Aguejouf O., Eizayaga F., Desplat V., Belon P., Doutremepuich C. Prothrombotic and hemorrhagic effects of aspirin. Clin Appl Thromb Hemost 2009; 15: 523-528.
  • 187 Cohen M.V., Downey J.M. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med 1996; 47: 21-29.
  • 188 Kim S.H., Naveen K.C., Kim H.J. et al. Glucose-containing flavones – their synthesis and antioxidant and neuroprotective activities. Bioorg Med Chem Lett 2009; 19: 6009-6013.
  • 189 Gupta C. The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation. Urol Res 2000; 28: 223-229.
  • 190 Weiner H.L., Friedman H., Miller A. et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-837.
  • 191 Faria A.M., Weiner H.L. Oral tolerance. Immunol Rev 2005; 206: 232-259.
  • 192 Ono T., Inoue M., Rashid M.H., Sumikawa K., Ueda H. Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism. Neurochem Int 2002; 41: 399-407.
  • 193 Kayser V., Benoist J.M., Neil A., Gautron M., Guilbaud G. Behavioural and electrophysiological studies on the paradoxical antinociceptive effects of an extremely low dose of naloxone in an animal model of acute and localized inflammation. Exp Brain Res 1988; 73: 402-410.
  • 194 Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 2002; 300: 588-596.
  • 195 Singh V.P., Patil C.S., Jain N.K., Singh A., Kulkarni S.K. Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice. Pharmacology 2003; 69: 115-122.
  • 196 Bastide P., Aubin B., Baronnet S. E'tude pharmacologique d'une preparation d'Apis mel. (7CH) vis-à-vis de l'erythème aux rayons U.V. chez le cobayes albinos. Ann Homeop Fr 1975; 3: 289-294.
  • 197 Bildet J., Guyot M., Bonini F., Grignon M.C., Poitevin B., Quilichini R. Mise en évidence des effets de dilutions d'Apis mellifica et d'Apium virus vis-à-vis de l'erythème provoqué par un rayonnement U.V. chez le cobaye. Ann Pharm Fr 1989; 47: 24-32.
  • 198 Conforti A., Signorini A., Bellavite P. Effects of high dilutions of histamin and other natural compounds on acute inflammation in rats. In: Bornoroni C. (ed). Omeomed. Vol 92 1993. Bologna: Editrice Compositori; 163-169.
  • 199 Park H.J., Lee S.H., Son D.J. et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum 2004; 50: 3504-3515.
  • 200 Lee J.Y., Kang S.S., Kim J.H., Bae C.S., Choi S.H. Inhibitory effect of whole bee venom in adjuvant-induced arthritis. In Vivo 2005; 19: 801-805.
  • 201 Naidoo P., Pellow J. A randomized placebo-controlled pilot study of Cat saliva 9cH and Histaminum 9cH in cat allergic adults. Homeopathy 2013; 102: 123-129.
  • 202 Ugazio G., Koch R.R., Rechnagel R.O. Mechanism of protection against carbon tetrachloride by prior carbon tetrachloride administration. Exp Mol Path 1972; 16: 281-285.
  • 203 Pound A.W., Lawson T.A. Reduction of carbon tetrachloride toxicity by prior administration of a single small dose in mice and rats. Br J Exp Pathol 1975; 56: 172-179.
  • 204 Conforti A., Lussignoli S., Bertani S., Ortolani R., Verlato G., Bellavite P. Intraperitoneal administration of adjuvant inhibits the development of adjuvant arthritis in rats. Int J Immunopathol Pharmacol 1995; 8: 113-121.
  • 205 Conforti A., Lussignoli S., Bertani S. et al. Specific and long-lasting suppression of rat adjuvant arthritis by low-dose Mycobacterium butyricum . Eur J Pharmacol 1997; 324: 241-247.
  • 206 Conforti A., Lussignoli S., Bertani S. et al. Cytokine and nitric oxide levels in a rat model of immunologic protection from adjuvant-induced arthritis. Int J Immunopathol Pharmacol 2001; 14: 153-160.
  • 207 Lapp C., Wurmser L., Ney J. Mobilization de l'arsenic fixéchez le cobaye sous l'influence des doses infinitesimales d'arseniate. Thérapie 1955; 10: 625-638.
  • 208 Cazin J.C., Cazin M., Gaborit J.L. et al. A study of the effect of decimal and centesimal dilutions of arsenic on the retention and mobilisation of arsenic in the rat. Hum Toxicol 1987; 6: 315-320.
  • 209 Kundu S.N., Mitra K., Bukhsh A.R. Efficacy of a potentized homoeopathic drug (Arsenicum-album-30) in reducing cytotoxic effects produced by arsenic trioxide in mice: III. Enzymatic changes and recovery of tissue damage in liver. Complement Ther Med 2000; 8: 76-81.
  • 210 Banerjee P., Biswas S.J., Belon P., Khuda-Bukhsh A.R. A potentized homeopathic drug, arsenicum album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice. J Vet Med A Physiol Pathol Clin Med 2007; 54: 370-376.
  • 211 Banerjee P., Bhattacharyya S.S., Pathak S., Naoual B., Belon P., Khuda-Bukhsh A.R. Comparative efficacy of two microdoses of a potentized homeopathic drug, arsenicum album, to ameliorate toxicity induced by repeated sublethal injections of arsenic trioxide in mice. Pathobiology 2008; 75: 156-170.
  • 212 De Gerlache J., Lans M. Modulation of experimental rat liver carcinogenesis by ultra low doses of the carcinogens. In: Doutremepuich C. (ed). Ultra Low Doses. 1991. London: Taylor Francis; 17-26.
  • 213 Waddell W.J. Critique of dose response in carcinogenesis. Hum Exp Toxicol 2006; 25: 413-436.
  • 214 Cui X., Su J., Li Y. et al. Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model. Intensive Care Med 2010; 36: 148-156.
  • 215 Magnani P., Conforti A., Zanolin E., Marzotto M., Bellavite P. Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl) 2010; 210: 533-545.
  • 216 Bode A.M., Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 2002; 42: 5-24.
  • 217 Van Wijk R., Wiegant F.A.C. Stimulation of self-recovery by similia principle. Mode of testing in fundamental research. Br Homeopath J 1995; 84: 131-139.
  • 218 Bellavite P., Chirumbolo S., Lippi G., Andrioli G., Bonazzi L., Ferro I. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils. Cell Biochem Funct 1993; 11: 231-239.
  • 219 Bellavite P., Chirumbolo S., Santonastaso C., Biasi D., Lussignoli S., Andrioli G. Dose-dependence of the various functional responses of neutrophils to formylpeptides. Activation, regulation, and inverse effects according to the agonist dose and cell condition. In: Bastide M. (ed). Signals and Images. 1997. Dordrecht: Kluwer Acad. Publ.; 111-119.
  • 220 Preethi K.C., Kuttan G., Kuttan R. Anti-tumour activity of Ruta graveolens extract. Asian Pac J Cancer Prev 2006; 7: 439-443.
  • 221 Sunila E.S., Kuttan R., Preethi K.C., Kuttan G. Dynamized preparations in cell culture. Evid Based Complement Alternat Med 2009; 6: 257-263.
  • 222 Doutremepuich C., De Seze O., Anne M.C., Hariveau E., Quilichini R. Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers. Thromb Res 1987; 47: 373-377.
  • 223 Doux J.D., Bazar K.A., Lee P.Y., Yun A.J. Can chronic use of anti-inflammatory agents paradoxically promote chronic inflammation through compensatory host response?. Med Hypotheses 2005; 65: 389-391.
  • 224 Oberbaum M., Samuels N., Singer S.R. Hormesis is not homeopathy. Toxicol Appl Pharmacol 2005; 206: 365.
  • 225 Teixeira M.Z. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses 2003; 60: 276-283.
  • 226 Teixeira M.Z. Antidepressants, suicidality and rebound effect: evidence of similitude?. Homeopathy 2009; 98: 114-121.
  • 227 Wilder J. Das “Ausgangswert-Gesetz”, ein unbeachtes biologisches Gesetz und seine Bedeutung fur Forschung und Praxis. Zeit d Gesamte Neur u Psych 1931; 137: 317.
  • 228 Wilder J. Stimulus and response: the law of initial value. Bristol: Wright; 1967.
  • 229 Lorenz E.N. Predictability does the flap of a butterfly's wings in Brazil set off a tornado in Texas?. Address at the Annual Meeting of the American Association for the Advancement of Science. Washington, DC. 1979. Cited in: The Essence of Chaos by Edward N. Lorenz, Seattle, WA: University of Washington Press 1993.
  • 230 Firth W.J. Chaos-predicting the unpredictable. Br Med J 1991; 303: 1565-1568.
  • 231 Shinbrot T., Grebogi C., Ott E., Yorke J.A. Using small perturbations to control chaos. Nature 1993; 363: 411-417.
  • 232 Moss F. Chaos under control. Nature 1994; 370: 596-597.
  • 233 Ramo P., Kesseli J., Yli-Harja O. Perturbation avalanches and criticality in gene regulatory networks. J Theor Biol 2006; 242: 164-170.
  • 234 Schwartz G.E., Russek L.G. Dynamical energy systems and modern physics: fostering the science and spirit of complementary and alternative medicine. [see comments] Altern Ther Health Med 1997; 3: 46-56.
  • 235 Song L.Z., Schwartz G.E., Russek L.G. Heart-focused attention and heart-brain synchronization: energetic and physiological mechanisms. Altern Ther Health Med 1998; 4: 44-52.
  • 236 Balleza E., varez-Buylla E.R., Chaos A., Kauffman S., Shmulevich I., Aldana M. Critical dynamics in genetic regulatory networks: examples from four kingdoms. PLoS ONE 2008; 3: e2456.
  • 237 Schubert C., Lambertz M., Nelesen R.A., Bardwell W., Choi J.B., Dimsdale J.E. Effects of stress on heart rate complexity – a comparison between short-term and chronic stress. Biol Psychol 2009; 80: 325-332.
  • 238 Morita K., Tsumoto K., Aihara K. Possible effects of depolarizing GABAA conductance on the neuronal input-output relationship: a modeling study. J Neurophysiol 2005; 93: 3504-3523.
  • 239 Gupta K., Singh H.P., Biswal B., Ramaswamy R. Adaptive targeting of chaotic response in periodically stimulated neural systems. Chaos 2006. 16 023116.
  • 240 Qi Y., Watts A.L., Kim J.W., Robinson P.A. Firing patterns in a conductance-based neuron model: bifurcation, phase diagram, and chaos. Biol Cybern 2013; 107: 15-24.
  • 241 Mishra N., Muraleedharan K.C., Paranjpe A.S., Munta D.K., Singh H., Nayak C. An exploratory study on scientific investigations in homeopathy using medical analyzer. J Altern Complement Med 2011; 17: 705-710.
  • 242 Mathur M. The concept of miasm – evolution and present day perspective. Homeopathy 2009; 98: 177-180.
  • 243 Milgrom L.R. Patient-practitioner-remedy (PPR) entanglement. Part 6. Miasms revisited: non-linear quantum theory as a model for the homeopathic process. Homeopathy 2004; 93: 154-158.
  • 244 Bellavite P., Pettigrew A. Miasms and modern pathology. Homeopathy 2004; 93: 65-66.
  • 245 Bell I.R., Baldwin C.M., Schwartz G.E. Translating a nonlinear systems theory model for homeopathy into empirical tests. Altern Ther Health Med 2002; 8: 58-66.
  • 246 Gulmen F.M. Energy medicine. Am J Chin Med 2004; 32: 651-658.
  • 247 Schmidt J.M. Is homeopathy a science? – continuity and clash of concepts of science within holistic medicine. J Med Humanit 2009; 30: 83-97.
  • 248 Bell I.R., Koithan M., Pincus D. Methodological implications of nonlinear dynamical systems models for whole systems of complementary and alternative medicine. Forsch Komplementmed 2012; 19 (Suppl. 01) 15-21.